---
document_datetime: 2023-09-21 20:20:50
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/udenyca-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: udenyca-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6966318
conversion_datetime: 2025-12-14 13:50:21.491838
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## UDENYCA

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2326/ 201901   | Periodic Safety Update EU Single assessment - pegfilgrastim                                                                                                                                                                                       | 19/09/2019 product                  | 22/11/2019                                     | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2326/201901. |
| II/0003              | To update section 4.6 of the SmPC to remove reference to the pregnancy and lactation registry listed as a category 3 study in the RMP. The Package Leaflet is updated accordingly. The updated RMP version 1.5 has also been submitted. Medicinal | 31/10/2019                          |                                                | SmPC and PL                      |                                                                                                                                           |

<!-- image -->

Medicinal product no longer authorised

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0004 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - 10/10/2019 |
| II/0001/G | This was an application for a group of variations. 28/03/2019                                                                                                                                                 |